What is the current annual EBITDA of MDLZ?

As of today, MDLZ annual EBITDA is $4.98B

What is 1-year change in MDLZ annual EBITDA?

MDLZ annual EBITDA is down -24.94% year-over-year

What is 3-year change in MDLZ annual EBITDA?

MDLZ annual EBITDA is up +1.12% over the past 3 years

How far is MDLZ annual EBITDA from its all-time high?

MDLZ annual EBITDA is currently -31.02% below its historical high of $7.22B set on December 31, 2010

How does MDLZ annual EBITDA rank versus sector peers?

MDLZ annual EBITDA is higher than 93.89% of companies in Consumer Defensive sector

When is MDLZ next annual earnings release?

As of today, the next annual earnings release for MDLZ has not been scheduled

What is the current quarterly EBITDA of MDLZ?

As of today, MDLZ quarterly EBITDA is $1.73B

What is MDLZ quarterly EBITDA most recent change?

MDLZ quarterly EBITDA was up +8.10% on March 31, 2026

What is 1-year change in MDLZ quarterly EBITDA?

MDLZ quarterly EBITDA is up +11.08% year-over-year

How far is MDLZ quarterly EBITDA from its all-time high?

MDLZ quarterly EBITDA is currently -60.11% below its historical high of $4.35B set on March 31, 2024

How does MDLZ quarterly EBITDA rank versus sector peers?

MDLZ quarterly EBITDA is higher than 95.33% of companies in Consumer Defensive sector

When is MDLZ next earnings release?

The next earnings release for MDLZ is on July 28, 2026

What is the current TTM EBITDA of MDLZ?

As of today, MDLZ TTM EBITDA is $6.29B

What is MDLZ TTM EBITDA most recent change?

MDLZ TTM EBITDA was up +2.83% on March 31, 2026

What is 1-year change in MDLZ TTM EBITDA?

MDLZ TTM EBITDA is up +15.56% year-over-year

How far is MDLZ TTM EBITDA from its all-time high?

MDLZ TTM EBITDA is currently -31.82% below its historical high of $9.22B set on March 31, 2024

How does MDLZ TTM EBITDA rank versus sector peers?

MDLZ TTM EBITDA is higher than 94.86% of companies in Consumer Defensive sector

When is MDLZ next earnings release?

The next earnings release for MDLZ is on July 28, 2026

MDLZ EBITDA History & Chart Since 1997

Annual EBITDA

$4.98B$1.65B-24.94%

December 31, 2025

Summary

Current Value: As of today, MDLZ annual EBITDA is $4.98B, down -24.94% on December 31, 2025
Historical Performance: MDLZ annual EBITDA is up +1.12% over the past 3 years, down -8.22% over the past 5 years
All-Time High Comparison: MDLZ annual EBITDA is currently -31.02% below its historical high of $7.22B set on December 31, 2010
3-Year Low Comparison: MDLZ annual EBITDA is +1.12% above its 3-year low of $4.92B reached on an earlier date
Sector Comparison: MDLZ annual EBITDA is higher than 93.89% of companies in Consumer Defensive sector

EBITDA Chart

Performance

MDLZ Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$4.98B	-24.9%	+1.1%	-8.2%	-31.0%
Quarterly EBITDA	Mar 31, 26	$1.73B	+11.1%	-9.0%	+12.0%	-15.8%
TTM EBITDA	Mar 31, 26	$6.29B	+15.6%	+14.0%	+11.8%	-16.4%
Price	May 18, 26	$61.64	-5.6%	-20.2%	-0.9%	+76.7%
PE Ratio	May 18, 26	30.56	+25.9%	+13.2%	+29.4%	+50.7%
Annual Revenue	Dec 31, 25	$38.54B	+5.8%	+22.4%	+45.0%	-21.7%
Annual EPS	Dec 31, 25	$1.89	-44.8%	-3.7%	-23.5%	-12.6%
	Dec 31, 25	$3.62B	-32.1%	-5.1%	-16.0%	-37.3%
Annual Net Income	Dec 31, 25	$2.47B	-46.7%	-9.5%	-30.9%	-1.2%

EBITDA Highs

MDLZ Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$6.88B	Dec 31, 23	-27.6%
5Y	$6.88B	Dec 31, 23	-27.6%
All	$7.22B	Dec 31, 10	-31.0%

EBITDA Lows

MDLZ Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$4.92B	N/A	+1.1%
5Y	$4.92B	Dec 31, 22	+1.1%
All	$4.11B	Dec 1, 97	+21.1%

EBITDA History

Year	Value	Change
2025	$4.98B	-24.9%
2024	$6.63B	-3.5%
2023	$6.88B	+39.7%
2022	$4.92B	-13.5%
2021	$5.69B	+4.9%
2020	$5.42B	+2.8%
2019	$5.27B	+12.5%
2018	$4.69B	-10.0%
2017	$5.21B	+8.9%
2016	$4.78B	-6.2%
2015	$5.10B	-3.6%
2014	$5.29B	+6.5%
2013	$4.97B	-10.5%
2012	$5.55B	+2.7%
2011	$5.41B	-25.1%

Year	Value	Change
2010	$7.22B	+9.1%
2009	$6.61B	+9.8%
2008	$6.02B	+4.2%
2007	$5.78B	-5.9%
2006	$6.15B	+0.9%
2005	$6.09B	-1.6%
2004	$6.19B	-8.8%
2003	$6.79B	-3.1%
2002	$7.00B	+6.0%
2001	$6.61B	+5.2%
2000	$6.28B	+36.3%
1999	$4.61B	+0.8%
1998	$4.57B	+11.2%
1997	$4.11B	-

FAQ

What is the current annual EBITDA of MDLZ?
As of today, MDLZ annual EBITDA is $4.98B
What is 1-year change in MDLZ annual EBITDA?
MDLZ annual EBITDA is down -24.94% year-over-year
What is 3-year change in MDLZ annual EBITDA?
MDLZ annual EBITDA is up +1.12% over the past 3 years
How far is MDLZ annual EBITDA from its all-time high?
MDLZ annual EBITDA is currently -31.02% below its historical high of $7.22B set on December 31, 2010
How does MDLZ annual EBITDA rank versus sector peers?
MDLZ annual EBITDA is higher than 93.89% of companies in Consumer Defensive sector
When is MDLZ next annual earnings release?
As of today, the next annual earnings release for MDLZ has not been scheduled

Quarterly EBITDA

$1.73B$130.00M+8.10%

March 31, 2026

Summary

Current Value: As of today, MDLZ quarterly EBITDA is $1.73B, up +8.10% on March 31, 2026
Historical Performance: MDLZ quarterly EBITDA is up +11.08% year-over-year, down -8.98% over the past 3 years
All-Time High Comparison: MDLZ quarterly EBITDA is currently -60.11% below its historical high of $4.35B set on March 31, 2024
3-Year Low Comparison: MDLZ quarterly EBITDA is +81.76% above its 3-year low of $954.00M reached on June 30, 2024
Sector Comparison: MDLZ quarterly EBITDA is higher than 95.33% of companies in Consumer Defensive sector

Performance

MDLZ Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Mar 31, 26	$1.73B	+8.1%	+11.1%	-9.0%	+12.0%
Annual EBITDA	Dec 31, 25	$4.98B	–	-24.9%	+1.1%	-8.2%
TTM EBITDA	Mar 31, 26	$6.29B	+2.8%	+15.6%	+14.0%	+11.8%
Price	May 18, 26	$61.64	+2.6%	-5.6%	-20.2%	-0.9%
PE Ratio	May 18, 26	30.56	-3.9%	+25.9%	+13.2%	+29.4%
Quarterly Revenue	Mar 31, 26	$10.08B	-4.0%	+8.2%	+10.0%	+39.3%
Quarterly EPS	Mar 31, 26	$0.44	-15.4%	+41.4%	-71.3%	-35.6%
	Mar 31, 26	$1.39B	+11.1%	+12.4%	-13.2%	+10.1%
Quarterly Net Income	Mar 31, 26	$564.00M	-15.7%	+38.6%	-73.0%	-41.7%

Quarterly EBITDA Highs

MDLZ Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.73B	Mar 31, 26	at high
3Y	$4.35B	Mar 31, 24	-60.1%
5Y	$4.35B	Mar 31, 24	-60.1%
All	$4.35B	Mar 31, 24	-60.1%

Quarterly EBITDA Lows

MDLZ Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.42B	Sep 30, 25	+22.3%
3Y	$954.00M	Jun 30, 24	+81.8%
5Y	$954.00M	Jun 30, 24	+81.8%
All	$839.00M	Jun 30, 18	+106.7%

Quarterly EBITDA History

Month	Value	Change
Mar 2026	$1.73B	+8.1%
Dec 2025	$1.60B	+13.1%
Sep 2025	$1.42B	-7.5%
Jun 2025	$1.53B	-1.8%
Mar 2025	$1.56B	+20.9%
Dec 2024	$1.29B	-21.1%
Sep 2024	$1.64B	+71.5%
Jun 2024	$954.00M	-78.1%
Mar 2024	$4.35B	+179.9%
Dec 2023	$1.55B	-8.5%
Sep 2023	$1.70B	+4.4%
Jun 2023	$1.63B	-14.6%
Mar 2023	$1.91B	+79.0%
Dec 2022	$1.06B	-21.0%
Sep 2022	$1.35B	+12.2%
Jun 2022	$1.20B	-11.8%
Mar 2022	$1.36B	-0.9%
Dec 2021	$1.37B	-9.8%
Sep 2021	$1.52B	+21.4%
Jun 2021	$1.26B	-18.9%
Mar 2021	$1.55B	+2.8%
Dec 2020	$1.51B	+5.9%
Sep 2020	$1.42B	+23.8%
Jun 2020	$1.15B	-14.8%
Mar 2020	$1.35B	+4.1%
Dec 2019	$1.30B	-2.6%
Sep 2019	$1.33B	+1.9%
Jun 2019	$1.31B	-3.0%
Mar 2019	$1.35B	+10.2%
Dec 2018	$1.22B	+0.2%
Sep 2018	$1.22B	+45.3%
Jun 2018	$839.00M	-40.4%
Mar 2018	$1.41B	-13.1%
Dec 2017	$1.62B	+12.7%
Sep 2017	$1.44B	+21.5%
Jun 2017	$1.18B	-12.2%
Mar 2017	$1.35B	+20.9%
Dec 2016	$1.12B	-9.7%
Sep 2016	$1.24B	+6.5%
Jun 2016	$1.16B	-7.3%
Mar 2016	$1.25B	+11.2%
Dec 2015	$1.13B	-9.4%
Sep 2015	$1.24B	-5.7%
Jun 2015	$1.32B	+0.3%
Mar 2015	$1.31B	-13.1%
Dec 2014	$1.51B	+15.5%
Sep 2014	$1.31B	-1.4%
Jun 2014	$1.33B	+17.3%
Mar 2014	$1.13B	-21.3%
Dec 2013	$1.44B	-9.2%
Sep 2013	$1.58B	+38.3%

Month	Value	Change
Jun 2013	$1.14B	-5.1%
Mar 2013	$1.21B	-15.0%
Dec 2012	$1.42B	-36.4%
Sep 2012	$2.23B	-7.6%
Jun 2012	$2.41B	+10.2%
Mar 2012	$2.19B	+149.9%
Dec 2011	$876.00M	-58.7%
Sep 2011	$2.12B	-3.9%
Jun 2011	$2.21B	+7.2%
Mar 2011	$2.06B	+27.3%
Dec 2010	$1.62B	-11.1%
Sep 2010	$1.82B	-10.5%
Jun 2010	$2.03B	+17.0%
Mar 2010	$1.74B	+48.1%
Dec 2009	$1.17B	-39.3%
Sep 2009	$1.93B	+18.0%
Jun 2009	$1.64B	+9.4%
Mar 2009	$1.50B	+15.1%
Dec 2008	$1.30B	+1.7%
Sep 2008	$1.28B	-26.5%
Jun 2008	$1.74B	+18.4%
Mar 2008	$1.47B	+4.8%
Dec 2007	$1.40B	0.0%
Sep 2007	$1.40B	-10.1%
Jun 2007	$1.56B	+9.9%
Mar 2007	$1.42B	-11.4%
Dec 2006	$1.60B	+6.2%
Sep 2006	$1.51B	-8.3%
Jun 2006	$1.65B	+13.3%
Mar 2006	$1.45B	-16.2%
Dec 2005	$1.73B	+23.3%
Sep 2005	$1.41B	-7.8%
Jun 2005	$1.52B	+6.7%
Mar 2005	$1.43B	-9.6%
Dec 2004	$1.58B	+4.3%
Sep 2004	$1.52B	-2.4%
Jun 2004	$1.55B	+3.1%
Mar 2004	$1.51B	-10.7%
Dec 2003	$1.69B	+5.8%
Sep 2003	$1.60B	-12.5%
Jun 2003	$1.82B	+8.4%
Mar 2003	$1.68B	-15.9%
Dec 2002	$2.00B	+14.7%
Sep 2002	$1.74B	-7.4%
Jun 2002	$1.88B	+14.5%
Mar 2002	$1.64B	-6.2%
Dec 2001	$1.75B	+11.9%
Sep 2001	$1.57B	-11.8%
Jun 2001	$1.78B	+39.0%
Mar 2001	$1.28B	-

FAQ

What is the current quarterly EBITDA of MDLZ?
As of today, MDLZ quarterly EBITDA is $1.73B
What is MDLZ quarterly EBITDA most recent change?
MDLZ quarterly EBITDA was up +8.10% on March 31, 2026
What is 1-year change in MDLZ quarterly EBITDA?
MDLZ quarterly EBITDA is up +11.08% year-over-year
How far is MDLZ quarterly EBITDA from its all-time high?
MDLZ quarterly EBITDA is currently -60.11% below its historical high of $4.35B set on March 31, 2024
How does MDLZ quarterly EBITDA rank versus sector peers?
MDLZ quarterly EBITDA is higher than 95.33% of companies in Consumer Defensive sector
When is MDLZ next earnings release?
The next earnings release for MDLZ is on July 28, 2026

TTM EBITDA

$6.29B$173.00M+2.83%

March 31, 2026

Summary

Current Value: As of today, MDLZ TTM EBITDA is $6.29B, up +2.83% on March 31, 2026
Historical Performance: MDLZ TTM EBITDA is up +15.56% year-over-year, up +13.99% over the past 3 years
All-Time High Comparison: MDLZ TTM EBITDA is currently -31.82% below its historical high of $9.22B set on March 31, 2024
3-Year Low Comparison: MDLZ TTM EBITDA is +15.56% above its 3-year low of $5.44B reached on March 31, 2025
Sector Comparison: MDLZ TTM EBITDA is higher than 94.86% of companies in Consumer Defensive sector

Performance

MDLZ Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Mar 31, 26	$6.29B	+2.8%	+15.6%	+14.0%	+11.8%
Annual EBITDA	Dec 31, 25	$4.98B	–	-24.9%	+1.1%	-8.2%
Quarterly EBITDA	Mar 31, 26	$1.73B	+8.1%	+11.1%	-9.0%	+12.0%
Price	May 18, 26	$61.64	+2.6%	-5.6%	-20.2%	-0.9%
PE Ratio	May 18, 26	30.56	-3.9%	+25.9%	+13.2%	+29.4%
TTM Revenue	Mar 31, 26	$39.30B	+2.0%	+7.8%	+19.5%	+45.0%
TTM EPS	Mar 31, 26	$2.02	+6.8%	-25.0%	-29.6%	-23.4%
	Mar 31, 26	$4.91B	+3.2%	+18.8%	+12.1%	+9.6%
TTM Net Income	Mar 31, 26	$2.62B	+6.4%	-27.4%	-33.7%	-30.9%

TTM EBITDA Highs

MDLZ TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$6.29B	Mar 31, 26	at high
3Y	$9.22B	Mar 31, 24	-31.8%
5Y	$9.22B	Mar 31, 24	-31.8%
All	$9.22B	Mar 31, 24	-31.8%

TTM EBITDA Lows

MDLZ TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$5.44B	N/A	+15.6%
3Y	$5.44B	Mar 31, 25	+15.6%
5Y	$4.97B	Dec 31, 22	+26.5%
All	$1.28B	Mar 31, 01	+392.5%

TTM EBITDA History

Month	Value	Change
Mar 2026	$6.29B	+2.8%
Dec 2025	$6.12B	+5.4%
Sep 2025	$5.80B	-3.6%
Jun 2025	$6.02B	+10.6%
Mar 2025	$5.44B	-33.9%
Dec 2024	$8.23B	-3.1%
Sep 2024	$8.49B	-0.7%
Jun 2024	$8.55B	-7.3%
Mar 2024	$9.22B	+36.0%
Dec 2023	$6.78B	+7.8%
Sep 2023	$6.29B	+5.9%
Jun 2023	$5.94B	+7.7%
Mar 2023	$5.52B	+10.9%
Dec 2022	$4.97B	-5.9%
Sep 2022	$5.28B	-3.2%
Jun 2022	$5.46B	-1.0%
Mar 2022	$5.51B	-3.3%
Dec 2021	$5.70B	-2.3%
Sep 2021	$5.83B	+1.8%
Jun 2021	$5.73B	+1.9%
Mar 2021	$5.63B	+3.7%
Dec 2020	$5.43B	+4.0%
Sep 2020	$5.22B	+1.8%
Jun 2020	$5.12B	-3.0%
Mar 2020	$5.28B	+0.1%
Dec 2019	$5.28B	+1.4%
Sep 2019	$5.20B	+2.2%
Jun 2019	$5.09B	+10.1%
Mar 2019	$4.62B	-1.3%
Dec 2018	$4.69B	-7.8%
Sep 2018	$5.09B	-4.1%
Jun 2018	$5.31B	-6.1%
Mar 2018	$5.65B	+1.1%
Dec 2017	$5.59B	+9.9%
Sep 2017	$5.09B	+4.2%
Jun 2017	$4.88B	+0.5%
Mar 2017	$4.86B	+2.0%
Dec 2016	$4.76B	-0.2%
Sep 2016	$4.77B	-0.1%
Jun 2016	$4.78B	-3.2%
Mar 2016	$4.94B	-1.2%
Dec 2015	$5.00B	-7.2%
Sep 2015	$5.38B	-1.2%
Jun 2015	$5.45B	-0.2%
Mar 2015	$5.46B	+3.5%
Dec 2014	$5.28B	+1.4%
Sep 2014	$5.20B	-5.0%
Jun 2014	$5.47B	+3.4%
Mar 2014	$5.29B	-1.4%
Dec 2013	$5.37B	+0.3%
Sep 2013	$5.35B	-10.8%

Month	Value	Change
Jun 2013	$6.00B	-17.5%
Mar 2013	$7.27B	-11.9%
Dec 2012	$8.25B	+7.0%
Sep 2012	$7.71B	+1.4%
Jun 2012	$7.60B	+2.8%
Mar 2012	$7.40B	+1.8%
Dec 2011	$7.27B	-9.3%
Sep 2011	$8.01B	+3.9%
Jun 2011	$7.70B	+2.3%
Mar 2011	$7.53B	+4.5%
Dec 2010	$7.21B	+6.6%
Sep 2010	$6.76B	-1.6%
Jun 2010	$6.87B	+6.1%
Mar 2010	$6.48B	+3.9%
Dec 2009	$6.24B	-2.0%
Sep 2009	$6.37B	+11.5%
Jun 2009	$5.71B	-1.8%
Mar 2009	$5.81B	+0.5%
Dec 2008	$5.79B	-1.7%
Sep 2008	$5.89B	-2.1%
Jun 2008	$6.01B	+3.1%
Mar 2008	$5.83B	+0.9%
Dec 2007	$5.78B	-3.3%
Sep 2007	$5.98B	-1.7%
Jun 2007	$6.09B	-1.4%
Mar 2007	$6.17B	-0.5%
Dec 2006	$6.21B	-2.1%
Sep 2006	$6.34B	+1.7%
Jun 2006	$6.23B	+2.0%
Mar 2006	$6.11B	+0.4%
Dec 2005	$6.09B	+2.6%
Sep 2005	$5.94B	-1.8%
Jun 2005	$6.05B	-0.5%
Mar 2005	$6.08B	-1.3%
Dec 2004	$6.15B	-1.7%
Sep 2004	$6.26B	-1.3%
Jun 2004	$6.34B	-4.1%
Mar 2004	$6.61B	-2.6%
Dec 2003	$6.79B	-4.4%
Sep 2003	$7.10B	-2.0%
Jun 2003	$7.24B	-0.8%
Mar 2003	$7.30B	+0.5%
Dec 2002	$7.26B	+3.5%
Sep 2002	$7.02B	+2.6%
Jun 2002	$6.84B	+1.6%
Mar 2002	$6.73B	+5.7%
Dec 2001	$6.37B	+37.9%
Sep 2001	$4.62B	+51.3%
Jun 2001	$3.05B	+139.0%
Mar 2001	$1.28B	-

FAQ

What is the current TTM EBITDA of MDLZ?
As of today, MDLZ TTM EBITDA is $6.29B
What is MDLZ TTM EBITDA most recent change?
MDLZ TTM EBITDA was up +2.83% on March 31, 2026
What is 1-year change in MDLZ TTM EBITDA?
MDLZ TTM EBITDA is up +15.56% year-over-year
How far is MDLZ TTM EBITDA from its all-time high?
MDLZ TTM EBITDA is currently -31.82% below its historical high of $9.22B set on March 31, 2024
How does MDLZ TTM EBITDA rank versus sector peers?
MDLZ TTM EBITDA is higher than 94.86% of companies in Consumer Defensive sector
When is MDLZ next earnings release?
The next earnings release for MDLZ is on July 28, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

MDLZ Official Website www.mondelezinternational.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1103982/000162828026005345/0001628280-26-005345-index.htm
MDLZ Profile on Yahoo Finance finance.yahoo.com/quote/MDLZ
MDLZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdlz